Exchange: OTC·Updated 03:51 PM EDT

ADAPY Adaptimmune Therapeutics Plc - ADR

$0.0225
$0.0005
(2.17%)
Today
Reported EarningsAug 13
Mkt Cap$5.96M
Vol86,462.00

About ADAPY

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
80

Extremely Bullish Sentiment

How do you feel about ADAPY?

US_Bull
$ADAPY Sell at your own peril after holding this long cause you are getting 'bored' or 'tired' of holding but know that when it really maters you may not be able to load up. Day to day means absolutely squat when we know in the end we are gonna get paid and that gives me solace. Don't pay attention to 11% in green it will get dropped again no doubt about it but I have stopped giving an f cause I know ultimately patience is gonna pay me. I am gonna step back a bit I have said what I wanted to say I'll be watching the board now it is Pipers and you guys resp. to keep the board going lol... Peace out on the other end....
17
US_Bull
$ADAPY Fair enough Piper great point you are onto something maybe we are close to something between now and October 2.
1
7
PaidPiper
$ADAPY we have a statement of confirmation due tmro-Oct 2nd. That might give more insight into what they've been doing from May 30th to now. Either way, make money elsewhere while we wait. That's what I do
2
4
Hodl707
$ADAPY yes, the remaining assets are almost certainly aligned with an undisclosed buyer. Not hype. Not guessing. Not fantasy. Just corporate structure behaving exactly like a company whose last assets are already spoken for but not yet publicly announced.
1
8
US_Bull
$ADAPY Yes in the end we all want to make money with our investments but it gives me so much pleasure supporting and being invested in a company that daily saves lives worldwide like Kaela when these sarcoma patients have no other option in an aggressively advancing cancer form.
8
duepillagence
$ADAPY Yes this will happen.. and it will be the "purchaser" of our PRAME therapy (immatics or immunocore) as our whole IP estate is necessary to fill voids that both are vulnerable to and where adaptimmune reigns supreme.. When you follow the science it's hella obvious lol!!
2
4
Hodl707
$ADAPY the reason Chris Hill stays on as Director after his CFO contract ends is simple: ✔ He is needed to sign closing documents ✔ He is needed to maintain the entity until the transaction completes ✔ He is needed for PRAME/CD70/platform disposition ✔ He is needed for year‑end TSP completion ✔ He is needed for board‑level approvals ✔ He is not needed for operations — because operations are over This is exactly what companies do when they’re in the pre‑announcement → closing phase. Yes piper is right !!
9
michele3
$ADAPY Everyone is doing great job at finding out all pertaining things. But the reality is that we’re trading @ 0.02 and we haven’t got any news in months. Seems like smoking mirrors
1
2
Hodl707
$ADAPY even though we don’t own the Ass asset, we made it possible hopefully September is our month
9
PaidPiper
$ADAPY just want to point out that nothing has changed in our thesis we spent the last year piecing together. If you expected news already and it didn't come, doesn't mean it's not coming
9
duepillagence
$ADAPY They are monetizing recent batches of lentiviral vector since they're the supplier for this very recent trial herlev hospital (really ccti):
9
duepillagence
$ADAPY Imagine again, the PRAME program derived allogeneically, edited off an iPSC chassis to form universal master cell banks??? 🤑😳👀
1
3
PaidPiper
$ADAPY 5 weeks since PROC data was made available to Adap. Probably quielty sharing the data under confidentiality to potential suitors. They wouldn't necessarily be starting from zero on August 12; the new clinical info could simply be the piece needed to advance an existing process
1
4
manny11419
$ADAPY After perusing the AR again..its seems that mgmt wants the shell to continue for a while...is quite possible that they'll structured any future technology sale as a long term events, such as a partnership for the Platform technology. I had hope the company close up shop by December and make a distribution. Many shareholders are getting tired of waiting and want to move on. I believe the actives on this board hold a large chuck of shares maybe we can force the issue...write to the BOD..they are legally bound to read all shareholders letters...I personally own 1.2 million shares..if we can 30% of more we can get a quorum. I believe the threshold for Adapy is 30%.
1
5
manny11419
$ADAPY Quantitatively speaking...with $32 million in net equity and $7 million added recently, investors buying at these prices can't lose. Aside from the usual "act of God" risks.....there's only one scenario where one can lose here.....if mgmt decided to continue/accelerate operations indefinitely burning up cash. I will continue to buy.
1
5
KJ18
$ADAPY why is everyone bullish? I have owned this company since it was $1.10 and I have no hope of ever getting my money back. I am hoping at this point they close shop so I can take tax deductions
1
1
HellasManN10
$ADAPY It is extraordinarily interesting to be a week ahead; you can understand so many things.
1
3
Stockinvestor73
not quite jackass. when the acquiror goes through a reverse merger they do not have to split...... keep being ignorant $ADAPY $XBOTF LOL LMFAO LOLOLOLOLOLOLOLOLOLOLOLO
7
manny11419
$ADAPY lots of manipulation...low bidders are trying to unnerve tired holders to unload...it'll work for some.
1
3
shanegeano
$ADAPY Anyone have any information on this one? Sentiment is bullish and I am too. Just hard to find info.
1
2

Advertisement|Remove ads.